These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37059463)

  • 1. When I use a word . . . Medical definitions: Pharmacovigilance.
    Aronson JK
    BMJ; 2023 Apr; 381():855. PubMed ID: 37059463
    [No Abstract]   [Full Text] [Related]  

  • 2. When I use a word . . . Medical definitions: Pharmacovigilance signals.
    Aronson JK
    BMJ; 2023 May; 381():1032. PubMed ID: 37146998
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adverse drug reaction - Definitions, risk factors and pharmacovigilance].
    Krähenbühl S
    Ther Umsch; 2015 Dec; 72(11-12):669-71. PubMed ID: 26654809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology.
    Baldo P; Francescon S; Fornasier G
    Int J Clin Pharm; 2018 Aug; 40(4):748-753. PubMed ID: 30094557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visualising Patterns Associated with Adverse Drug Reactions in French Forums.
    Allam N; Audeh B; Jaulent MC; Bousquet C
    Stud Health Technol Inform; 2021 May; 281():1110-1111. PubMed ID: 34042861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causality assessment in pharmacovigilance: The French method and its successive updates.
    Miremont-Salamé G; Théophile H; Haramburu F; Bégaud B
    Therapie; 2016 Apr; 71(2):179-86. PubMed ID: 27080836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in adverse drug reactions reported to the National Pharmacovigilance Centre in the Netherlands: An explorative observational study.
    de Vries ST; Denig P; Ekhart C; Burgers JS; Kleefstra N; Mol PGM; van Puijenbroek EP
    Br J Clin Pharmacol; 2019 Jul; 85(7):1507-1515. PubMed ID: 30941789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. French pharmacovigilance: Missions, organization and perspectives.
    Vial T
    Therapie; 2016 Apr; 71(2):143-50. PubMed ID: 27080832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current trends in pharmacovigilance: value and gaps of patient reporting.
    Inácio P; Cavaco A; Airaksinen M
    Int J Clin Pharm; 2018 Aug; 40(4):754-757. PubMed ID: 30006734
    [No Abstract]   [Full Text] [Related]  

  • 10. [Causality assessment in reports on adverse drug reactions. Algorithm of Spanish pharmacovigilance system].
    Aguirre C; García M
    Med Clin (Barc); 2016 Nov; 147(10):461-464. PubMed ID: 27450163
    [No Abstract]   [Full Text] [Related]  

  • 11. Comment on: "Pharmacovigilance in the Middle East".
    Al-Worafi YM
    Drug Saf; 2014 Aug; 37(8):651-2. PubMed ID: 24985531
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of discrepancies between adverse drug reactions coded by medical records technicians and those reported by the pharmacovigilance team in pediatrics: An intervention to improve identification, reporting, and coding.
    Soyer J; Necsoiu D; Desjardins I; Lebel D; Bussières JF
    Arch Pediatr; 2019 Oct; 26(7):400-406. PubMed ID: 31611146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacovigilance in Russia: current state of affairs, challenges, and prospects.
    Gildeeva G; Belostotsky A
    Curr Med Res Opin; 2017 Dec; 33(12):2161-2166. PubMed ID: 28562116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacovigilance: Importance, concepts, and processes.
    Kumar A
    Am J Health Syst Pharm; 2017 Apr; 74(8):606-612. PubMed ID: 28235869
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse drug reactions in neonates: could we be documenting more?
    Hawcutt DB; O'Connor O; Turner MA
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):807-20. PubMed ID: 25225053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial intelligence in pharmacovigilance: A regulatory perspective on explainability.
    Pinheiro LC; Kurz X
    Pharmacoepidemiol Drug Saf; 2022 Dec; 31(12):1308-1310. PubMed ID: 35959980
    [No Abstract]   [Full Text] [Related]  

  • 17. Bismuth and pharmacovigilance.
    Trenque T
    Therapie; 2021; 76(5):383-384. PubMed ID: 33218671
    [No Abstract]   [Full Text] [Related]  

  • 18. Systematic collection of patient-reported adverse drug reactions: a path to patient-centred pharmacovigilance.
    Basch E
    Drug Saf; 2013 Apr; 36(4):277-8. PubMed ID: 23508543
    [No Abstract]   [Full Text] [Related]  

  • 19. Measuring the impact of pharmacovigilance activities, challenging but important.
    van Hunsel F; Gardarsdottir H; de Boer A; Kant A
    Br J Clin Pharmacol; 2019 Oct; 85(10):2235-2237. PubMed ID: 31368147
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-Drug Interactions: A Pharmacovigilance Road Less Traveled.
    Price J
    Clin Ther; 2023 Feb; 45(2):94-98. PubMed ID: 36641261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.